Notes: February 4, 2024 -- Cano Health, Inc. (the “Company”) and certain of its direct and indirect subsidiaries (such subsidiaries, together with the Company, the “Debtors”), entered into a Restructuring Support Agreement (together with the Restructuring Term Sheet and all other exhibits and schedules attached thereto, the “RSA”) with lenders holding approximately (x) 86% of its secured revolving and term loan debt and (y) 92% of its senior unsecured notes (collectively, the “Consenting Creditors”), which, among other things, sets forth the principal terms of a proposed financial restructuring (the “Restructuring”) of the existing capital structure of the Company in voluntary cases (the “Chapter 11 Cases”) commenced by the Debtors in the U.S. Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”) under chapter 11 of title 11 of the U.S. Code (the “Bankruptcy Code”). Capitalized terms used but not defined herein have the meanings ascribed to them in the RSA. <p> June 03, 2021 -- Cano Health, Inc. (“Cano Health,” the “Company,” “we,” “our” or “us”), a leading value-based primary care provider for seniors and underserved communities, today announced it has completed its business combination with Jaws Acquisition Corp. (“Jaws”) (NYSE: JWS). The business combination, which was approved by Jaws’ stockholders at its special meeting held on June 2, 2021, will enable Cano Health to achieve its vision of becoming America’s leader in primary care and accelerate the Company’s growth. Beginning June 4, 2021, Cano Health’s shares of Class A common stock will trade on the New York Stock Exchange (“NYSE”) under the symbol “CANO.”